Churchill Capital X Stock Price, News & Analysis

Churchill Capital Corp X (trading in unit form under the symbol CCCXU on the Nasdaq Stock Market LLC) is a blank check company, also known as a special purpose acquisition company (SPAC). It is classified in the Financial Services sector under Shell Companies. The company has been formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses and may pursue an initial business combination target in any business or industry.

According to its Nasdaq listing disclosures, each unit of Churchill Capital Corp X consists of one Class A ordinary share and one-quarter of one redeemable warrant. The units trade under the symbol CCCXU, the Class A ordinary shares trade under the symbol CCCX, and the warrants trade under the symbol CCCXW, each on the Nasdaq Stock Market LLC. Each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50 per share.

Churchill Capital Corp X is incorporated in the Cayman Islands and reports under Commission File Number 001-42646. As a SPAC, it raises capital through an initial public offering of units and places the proceeds in a trust account. Its stated objective, as described in multiple public communications, is to identify and complete a business combination with an operating company. It may evaluate potential targets across a broad range of sectors and geographies, subject to applicable regulatory approvals and shareholder consent.

Business Combination with Infleqtion

On September 8, 2025, Churchill Capital Corp X entered into an Agreement and Plan of Merger and Reorganization with ColdQuanta, Inc., which does business as Infleqtion, and two wholly owned merger subsidiaries. Under this merger agreement, Churchill intends to effect a two-step merger in which Infleqtion will become a wholly owned subsidiary of Churchill. The transactions contemplated by the merger agreement, together with related financing arrangements, are referred to as the "Transactions" in Churchill’s Form 8-K.

In connection with the Transactions, Churchill plans to undertake a domestication from a Cayman Islands exempted company to a corporation incorporated under the laws of the State of Delaware. As part of this domestication, Churchill will file a certificate of incorporation that, among other things, changes its name to "Infleqtion, Inc." and sets forth the rights and preferences of its equity interests following completion of the mergers. Each outstanding Class B ordinary share is expected to convert into a Class A ordinary share, and each Class A ordinary share will convert into a share of common stock of the domesticated entity. Each outstanding warrant to acquire Class A ordinary shares will convert into a warrant to acquire a corresponding number of shares of common stock of the domesticated entity, and each unit will be canceled in exchange for one share of common stock and one-quarter of one warrant of the domesticated entity, all on a one-for-one basis as described in the 8-K.

The merger consideration to Infleqtion’s stockholders and vested equity holders is based on a stated pre-money equity value of $1.8 billion for Infleqtion, which is used to calculate an exchange ratio defined in the merger agreement. At closing, each share of Infleqtion capital stock (subject to certain exceptions) will be cancelled and converted into the right to receive shares of common stock of the domesticated Churchill entity based on this exchange ratio. In addition, outstanding Infleqtion stock options and restricted stock awards are expected to be assumed and converted into options and restricted stock awards of the domesticated entity, on the terms set out in the merger agreement.

Regulatory and Shareholder Approvals

The closing of the Transactions is subject to a range of customary conditions for SPAC business combinations. These include expiration or termination of applicable antitrust waiting periods, specified clearances or non-objection outcomes under the UK National Security and Investment Act 2021 and Australia’s Foreign Acquisitions and Takeovers Act 1975, the absence of governmental orders preventing the deal, and effectiveness of a registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission. Churchill must also obtain approval of its shareholders for the merger agreement, the domestication, the issuance of shares in the Transactions and related matters, and Infleqtion must obtain approval of its stockholders for the merger agreement and the Transactions.

Additional closing conditions include Churchill having at least $5,000,001 of net tangible assets as of closing (including giving effect to any private investment in public equity, or PIPE, financing) and the domesticated entity’s common stock being approved for listing on Nasdaq or another mutually agreed stock exchange. For Infleqtion, completion of the Transactions is also conditioned on a minimum amount of available cash at closing, defined in the merger agreement as Available Closing SPAC Cash, being at least $100,000,000, along with the absence of specified material adverse effects with respect to Churchill.

The merger agreement contains customary termination rights, including mutual termination, termination if the Transactions are not consummated by a specified outside date, termination following failure to obtain required shareholder approvals, and termination in the event of certain uncured breaches or regulatory prohibitions. These provisions are summarized in Churchill’s Form 8-K filed on September 8, 2025.

Corporate Governance and Board Composition

Churchill Capital Corp X has disclosed changes to its board of directors and committee composition through its SEC filings. On July 29, 2025, the board appointed Paul D. Lapping and Stephen Murphy as directors, effective August 1, 2025. Mr. Murphy was appointed as a member of the compensation committee and the audit committee, and Mr. Lapping was appointed as chairperson of the audit committee, replacing the interim chairperson, who continues to serve as a member of the audit committee. In connection with their appointments, each new director entered into a joinder to an existing letter agreement with the company, its officers, directors and sponsor, agreeing, among other things, to waive certain redemption rights and to vote any ordinary shares they hold in favor of an initial business combination. The company also entered into standard director indemnity agreements and director compensation agreements providing for annual cash compensation for their board service.

Trading Structure and Unit Separation

Churchill Capital Corp X announced that, commencing on July 7, 2025, holders of its units issued in the initial public offering could elect to separately trade the Class A ordinary shares and the warrants included in the units. Units that are not separated continue to trade on the Nasdaq Global Market under the symbol CCCXU, while the Class A ordinary shares and the warrants trade under the symbols CCCX and CCCXW, respectively. No fractional warrants are issued upon separation, and only whole warrants trade. Each whole warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share.

Relationship with Infleqtion

Multiple public communications describe Infleqtion as a global leader in neutral-atom quantum technology that designs and builds quantum computers, precision sensors and quantum software for governments, enterprises and research institutions. Infleqtion’s commercial portfolio includes quantum computers, quantum RF systems, quantum clocks and inertial navigation solutions. Infleqtion has announced that it plans to become a publicly traded company through a merger with Churchill Capital Corp X, and Churchill has described Infleqtion as the target of its proposed initial business combination. Upon closing of the Transactions and domestication, the combined company is expected, according to public statements, to operate under the name Infleqtion, Inc. and to be listed on a leading North American exchange under the ticker symbol INFQ, subject to shareholder approvals, regulatory effectiveness of the registration statement and satisfaction of other closing conditions.

Investment Considerations

As a SPAC, Churchill Capital Corp X does not have an operating business of its own prior to completion of a business combination. Its value proposition to investors is tied to its ability to identify, negotiate and close a transaction with an operating company such as Infleqtion. The company’s SEC filings and joint press releases with Infleqtion outline the proposed transaction structure, the domestication process, the planned post-closing corporate name and listing, and the conditions and risks associated with completing the deal. Investors considering CCCXU, CCCX or CCCXW typically review these documents, including the registration statement on Form S-4 and related proxy statement/prospectus, for detailed information about the proposed combination, governance arrangements, risk factors and the business of Infleqtion.

FAQs about Churchill Capital Corp X (CCCXU)

• What is Churchill Capital Corp X?
  Churchill Capital Corp X is a blank check company, or special purpose acquisition company, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It is classified in the Shell Companies industry within the Financial Services sector.
• What does the CCCXU unit represent?
  Each CCCXU unit consists of one Class A ordinary share of Churchill Capital Corp X and one-quarter of one redeemable warrant. Units trade on the Nasdaq Global Market under the symbol CCCXU, while the Class A ordinary shares and warrants trade separately under CCCX and CCCXW, respectively, once holders elect to separate their units.
• What are the terms of the CCCXW warrants?
  Each whole CCCXW warrant is exercisable for one Class A ordinary share of Churchill Capital Corp X at an exercise price of $11.50 per share, as disclosed in the company’s SEC filings. No fractional warrants are issued; only whole warrants trade.
• What business combination has Churchill Capital Corp X announced?
  On September 8, 2025, Churchill Capital Corp X entered into an Agreement and Plan of Merger and Reorganization with ColdQuanta, Inc. (doing business as Infleqtion) and two merger subsidiaries. The agreement provides for a two-step merger in which Infleqtion will become a wholly owned subsidiary of Churchill, subject to shareholder approvals and other closing conditions.
• How will Churchill Capital Corp X change in connection with the Infleqtion merger?
  Subject to the conditions in the merger agreement, Churchill plans to domesticate from the Cayman Islands to Delaware and change its name to "Infleqtion, Inc." Each Class A ordinary share is expected to convert into a share of common stock of the domesticated entity, each warrant into a warrant to acquire common stock, and each unit into one share of common stock and one-quarter of one warrant, all on a one-for-one basis as described in the Form 8-K.
• What approvals are required for the Infleqtion transaction?
  The Transactions require approval by Churchill’s shareholders of the merger agreement, the domestication, the issuance of shares and related matters, as well as approval by Infleqtion’s stockholders. They are also subject to regulatory clearances, the effectiveness of a registration statement on Form S-4, satisfaction of minimum cash and net tangible asset conditions and the absence of specified material adverse effects.
• Does Churchill Capital Corp X have its own operating business?
  Churchill Capital Corp X is a SPAC and does not operate an ongoing business. Its purpose is to identify and complete a business combination with one or more operating businesses. Its proposed initial business combination is with Infleqtion, as described in its SEC filings and joint press releases.
• Where can investors find more detailed information on CCCXU and the proposed merger?
  Investors can review Churchill Capital Corp X’s filings with the U.S. Securities and Exchange Commission, including Forms 8-K describing the merger agreement and the registration statement on Form S-4 that includes a preliminary proxy statement/prospectus relating to the proposed business combination with Infleqtion. These documents provide detailed information about the SPAC, the target company and the terms and risks of the Transactions.